CN Stock MarketDetailed Quotes

600351 Yabao Pharmaceutical Group

Watchlist
  • 6.54
  • +0.10+1.55%
Noon Break Dec 2 11:29 CST
4.71BMarket Cap21.30P/E (TTM)

Yabao Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yabao Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
677.82M
--
+1.68%
EPS
--
0.08
--
--
Analyst Rating
Strong Buy

Dec 1, 2024

Yabao Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--

Yabao Pharmaceutical Group Earnings Reports

  • Yabao Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024 (Revised Edition)

    Oct 26 00:00

  • Yabao Pharmaceutical Group Co., Ltd. 2024 Third Quarter Report Correction Notice

    Oct 26 00:00

  • Yabao Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024

    Oct 25 00:00

  • Yabao Pharmaceutical Group Co., Ltd. 2024 Semi-annual Report

    Aug 15 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 1, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data